Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fixed Dose Subcutaneous Low Molecular Weight Heparins Versus Adjusted Dose Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431752/all/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism.
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/all/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism. Accessed February 19, 2025.
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/all/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism
Fixed Dose Subcutaneous Low Molecular Weight Heparins Versus Adjusted Dose Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/all/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
ID - 431752
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/all/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -